Remote Jobs at Kyverna Therapeutics
Find your next remote opportunity · 3 Open Positions
Kyverna Therapeutics is a clinical-stage cell therapy company with the mission of engineering a new class of therapies for autoimmune and inflammatory diseases.
The Kyverna therapeutic platform combines advanced T cell engineering and synthetic biology technologies to suppress and eliminate the autoreactive immune cells at the origin of autoimmune and inflammatory diseases.
Kyverna’s pipeline includes KYV-101, a fully human, autologous chimeric antigen receptor (CAR) T-cell therapy with properties well suited for use in B cell-driven autoimmune diseases and KYV-201, a fully human, allogeneic CAR T-cell therapy.
By offering more than one mechanism for taming autoimmunity, and with patients currently in treatment for multiple indications in the U.S. and Europe, Kyverna is positioned to act on its mission of transforming how autoimmune diseases are treated.
Senior Medical Director, Clinical Development
Sr. Medical Director engaged in clinical development of cell therapies for autoimmune diseases at Kyverna Therapeutics. Overseeing trials, strategy, and collaboration with cross-functional teams.
Director of Training – Global Medical Affairs
Director of Training in global medical affairs for cell therapy programs. Developing training strategies, content, and compliance across clinical and commercial stages in a remote role.
Executive Director, Safety & Pharmacovigilance
Executive Director of Safety & Pharmacovigilance overseeing global safety strategy for cell therapy pipeline. Leading a compliant and scalable safety organization, ensuring proactive risk management and regulatory compliance.
No more jobs available.